<DOC>
	<DOCNO>NCT03032848</DOCNO>
	<brief_summary>To evaluate difference three vaginal estrogen cream comparative placebo improvement hormonal cytology , local systemic climacteric complaint , well endometrial security .</brief_summary>
	<brief_title>Vaginal Estrogens Comparative Trial Pelvic Organ Prolapse Patients</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Endometrial Hyperplasia</mesh_term>
	<mesh_term>Atrophic Vaginitis</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>post menopause woman normal oncotic cytology mammogram grade pelvic organ prolapse surgery indication ultrasound endometrium measure le 5 mm vaginal bleed hormonal replacement past three month renal hepatic desease porfiria past venous thromboembolism ; ulcerated prolapse</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>